Phibro (PAHC) Reports Q3 2026 Earnings with Strong Performance
Phibro reported strong third-quarter results for 2026, with a 10% increase in net sales to $383 million and an 11% rise in adjusted EBITDA to $60 million. The Animal Health segment saw robust demand across multiple product lines.
Tickers: $PAHC